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ABSTRACT
The fusion molecule (i.e. aptazyme) of aptamer and
hammerhead ribozyme was developed as in situ
sensor. Previously, the hammerhead ribozyme con-
jugated with aptamer through its stem II module
showed a significant blank signal by self-cleavage.
To reduce or remove its self-cleavage activity in the
absence of target molecule, rational designs were
attempted by reducing the binding affinity of the
aptazyme to its RNA substrate, while maintaining
the ribonuclease activity of the aptazyme. Inter-
estingly, the bis-aptazymes which comprise the two
aptamer-binding sites at both stem I and stem III of
the hammerhead ribozyme showed very low blank
signals, and their ratios of reaction rate constants,
i.e.signaltonoiseratios,wereseveraltenstohundred
times higher than those of the stem II-conjugated
bis-aptazymes. The reduction in the blank signals
seemstobecausedbyahigherdissociationconstant
between the main strand of the bis-aptazyme and its
substrate arising from multi-point base-pairing of the
bis-aptazymes. The bis-aptazymes for HCV replicase
and helicase showed high selectivity against other
proteins, and a linear relationship existed between
their ribozyme activities and the target concentra-
tions. In addition, a bis-aptazyme of dual functions
was designed by inserting both aptamers for HCV
replicase and helicase into the stem I and stem III of
hammerhead ribozyme, respectively, and it also
showed greater sensitivity and specificity for both
proteins without blank signal.
INTRODUCTION
Analysis of cancer markers or disease related proteins has
become important issue in prognosis, diagnosis and treatment
of cancer and disease (1,2). For the detection of such speciﬁc
proteins in blood and tissue, antibody (Ab) is the most
common reagent used in autoradiography, enzyme-linked
immunosorbent assay (ELISA) and western blotting. Advan-
tages and drawbacks in using Ab are well documented. For
example, the use of secondary Ab in sandwich assay requires
Ab conjugated with enzyme or ﬂuorescent dye. Ab reaction
usually takes time and requires speciﬁc reaction conditions for
binding of target molecules. In addition, some antibodies are
temperature-sensitive, so that they are easily degraded during
long time handling. Therefore, development of alternative,
fast, temperature-resistant, sensitive and high-throughput
non-isotopic analytical methods to selectively detect target
molecules from complex mixtures is very much in need and
challenging (3). Recently, aptamers were introduced as a sub-
stitute for Abs in the application of biosensors for detection
and measurement of biological or environmental molecules
(4–9),because aptamers canbe easily developedfor molecules
for which we cannot generate Abs. As aptamers are rapidly
matured through in vitro evolution method (10), they show
almost equivalent or even better dissociation constants, com-
pared with Abs. As a variation of aptamer, aptazyme (or called
allosteric ribozyme) was developed as an in situ biosensor (7).
Since the aptazyme is a conjugated molecule between aptamer
and ribozyme, we can extract only the beneﬁcial properties of
both aptamer and ribozyme, i.e. high-binding afﬁnity and
sequence-speciﬁc nucleotide cleaving activity (11). Various
aptazymes were designed to transduce the binding energy of
small analyte molecules (12–14) or macromolecules (15) or
proteins (16) into the activation energy of the catalytic activity
of ribozyme (7,17–19). When aptazymes are used as biosen-
sors, sensitive detection is possible by signal ampliﬁcation
even at low target concentrations, because the catalytic activ-
ity of the aptazymes can be easily ampliﬁed by serial addition
of the corresponding substrate.
On the contrary, the disadvantages of using aptazymes as
biosensors are such that (i) maintaining complete binding
afﬁnity of aptamer moiety as well as the intact activity of
ribozyme moiety is not easy, (ii) aptazymes sometimes
show relatively high blank signals owing to the inherent
self-cleaving activity of ribozyme (20,21). The issue of
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doi:10.1093/nar/gni174high blank activity is very critical to develop the aptazyme as
biosensor, because the blank signal suppresses the sensitivity
of sensor and the limit of detection range. To solve
this problem, optimum aptazymes were screened and
selected by randomizing the sequence of linking module or
total aptazyme to reduce or remove the self-cleavage effect
(21). However, the in vitro evolution method is time-
consuming to develop and difﬁcult to apply for other mole-
cules except the selected target. As high-throughput screening
of aptamers driven by automation of in vitro selection
method (22) and a database of reported aptamers (23) are
provided, developing easy and rather simple, but general
design principles to make aptazymes without blank
signal, would be very useful to change them into smart
biosensors.
Here, we introduce a new design principle of aptazymes
to eliminate blank signal, and to enhance the catalytic
activity based upon the mechanism of self-cleaving hammer-
head ribozyme. Most previous approaches in constructing
allosteric fusion aptazyme were done through conjugation
of the stem II of hammerhead ribozyme, since the stem II
region was known to be the most sensitive module in exerting
the ribozyme activity (24). Unfortunately, the high sensitivity
of the stem II module in aptazymes often greatly inﬂuences
to yield high blank signal of the self-cleavage activity. There-
fore, rather less sensitive moiety of stem I or stem III
region was used for the conjugation with aptamers. Surpris-
ingly, inserting aptamers in both stem I and stem III regions
made the aptazymes very stable and sensitive. In this paper,
using aptamers for HCV replicase and HCV helicase and
hammerhead ribozyme as model systems, we would like to
explain how the fusion aptazymes are constructed, and
why the fused aptazymes are more stable without blank signal
and even more sensitive to target molecules. This kind of
approach in designing aptazymes will be very useful for the
development of in situ biosensors, protein chips and gene
therapy.
MATERIALS AND METHODS
Preparation of aptazyme
All single-stranded DNA (ssDNA) strands were synthesized
and puriﬁed by PAGE from IDT (Coralville, IA) and Cosmo
Co. (Seoul, Korea). ssDNA strands containing T7 promoter
region in 50 end region were ampliﬁed by PCR with 50 primer
and 30 primer. After gel puriﬁcation of DNA product, template
RNAs (Table 1) were prepared by in vitro transcription using
T7 RNA polymerase. All the RNA transcripts were separated
by 6% PAGE gel containing 8 M urea after phenol extraction
and ethanol precipitation. The puriﬁed RNAs once again were
dissolved in 0.1% diethylpyrocarbonate and stored at  80 C
for further experiments. The substrates for the aptazymes
were dual-labeled with 6-carboxyﬂuorescein (6-Fam) and 4-
dimethylaminoazobenzene-40-sulfonyl chloride (dabcyl) at 50
and 30 ends, respectively, and the 6-Fam-50-AGCCGUCUCG-
GUU-30-dabcyl of 13mer and 6-Fam-50-CCGGGGUCUCGG-
GGCC-30-dabcyl of 16mer synthetic RNAs were purchased
from IBA (Goettingen, Germany).
Purification of HCV replicase and
helicase protein
pET21a vectors cloned with HCV replicase and HCV helicase
were transformed into BL21(DE3) and the host cells were
cultured at 37 C. To over-express the proteins, 0.2 mM
isopropyl-b-D-thiogalactopyranoside was added to the cell
culture media at  0.5 of cell density (OD600). After 5 h from
the induction, the cells were harvested and the cell extract
was prepared by sonication in the 50 mM phosphate buffer
containing 1 mM phenylmethylsulfonyl ﬂuoride and 1 mM
EDTA for 20 min. The proteins containing six consecutive
histidine residues at their C-terminals were puriﬁed with
Ni-NTA agarose resin (Qiagen, Hilden, Germany). Imidazole
buffer (250 mM) used for the protein elution was removed by
dialysis against phosphate-buffered saline buffer, and quanti-
tative analysis of the proteins was performed by Bradford
assay.
The activity assay of aptazyme
Before the reaction withtarget protein, to retain RNA structure
in the binding buffer [10 mM Tris–HCl, 100 mM KCl and
10 mM MgCl2 (pH 7.6)], all the aptazymes used were pre-
incubated for10 min atroom temperatureafter heating at80 C
for 3 min. Each 1 mM designed aptazyme was reacted with
target protein for 20 min at room temperature. The aptazyme
and protein mixture were transferred to a 50 ml cuvette, the
reaction was started by adding 1 mM substrate. Reaction kinet-
ics of the aptazyme was measured by ﬂuorospectrometer
(Jasco, Tokyo, Japan). All the measurements were performed
in the binding buffer at 496 nm excitation wavelength and
516 nm emission wavelength (slit excitation size, 10 nm; slit
emission size, 10 nm). The reaction rate constant was obtained
by calculating {ln[(Ft   Fi)/Fi]/Dt} at each protein concen-
tration, assuming a ﬁrst-order kinetics. Here, Ft and Fi are the
Table 1. The sequences of designed aptazymes
Conjugation RNA sequences
Stem II (R) GGCCGACUGAUGAUGAGCUGGGCCACAUUGUGAGGGGCUCAGCGAAACGGCU
Stem II (H) GGCCGACUGAUGAUGAGCUGCCAGUAGUGUAUAGGGCAGCGAAACGGCU
Stem I (R) GGCCACGCGCCACAUUGUGAGGGGCGCGACCGACUGAUGAU GAGCGAAAGCGAAAACCCCGG
Stem III (H) GGCCCCGACUGAUGAUGAGCGAAAGCGAAACCCAGCCAGUAGUGUAUAGGGCACGG
Stem I/III (R–R) GGCCACGCGCCACAUUGUGAGGGGCGCGACCGACUGAUGAUGAGCGAAAGCGAAACCCAGGCGCCACAUUGUGAGGGGCGCCACGG
Stem I/III (H–H) GGCCAGGGCAGUAGUGUAUAGGCCCACCGACUGAUGAUGAGCGAAAGCGAAACCCAGCCAGUAGUGUAUAGGGCACGG
Stem I/III (R–H) GGCCCCGACUGAUGAUGAGCUGGGCCACAUUGUGAGGGGCUCAGCGAAACCCAGGCCAGUAGUGUAUAGGGCCACGG
R, aptazyme for HCV replicase, H, aptazyme for HCV helicase.
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of rate constants was deﬁned as the ratio of the reaction rate
constant in the presence of target protein to that in the absence
of target protein.
Analysis of interaction of bis-aptazyme and substrate
To measure the relative cleavage activities of the modiﬁed
hammerhead ribozymes, primary amine modiﬁed mutant sub-
strate (NH2-C6-CCGGGGUGUCGGGGCC) (IDT, Coralville,
IA) for the hammerhead ribozyme was immobilized on CNBr
agarose beads with the binding capacity of 7 mmol/10 ml
(Sigma, St Louis, MO) in 50 mM sodium bicarbonate buffer
(pH 8.0) for 2 h at room temperature. The residual functional
group on the bead was subsequently blocked by 1 M ethano-
lamine for overnight at 4 C. The substrate-bound beads were
washed three times by 50 mM sodium bicarbonate buffer and
two times by the reaction buffer [10 mM Tris–HCl, 100 mM
KCl and 10 mM MgCl2 (pH 7.6)]. Bis-aptazymes were labeled
with dUTP-ﬂuorescein using a terminal deoxynucleotidyl
transferase (Roche, Mannheim, Germany). The modiﬁed bis-
aptazyme was separated by 8 M urea 6% PAGE, and its total
amount was measured by ﬂuorospectrometer after elution.
Before binding to the beads, the ﬂuorescence labeled bis-
aptazyme was incubated for 3 min at 80 C and stored for
10 min at room temperature for stable RNA structure con-
formation. Aptazymes (20 pmol) were added to the beads and
reacted for 5 min at room temperature under mild mixing. The
beads were subsequently washed ﬁve times with binding
buffer, and then the 3 ml beads were transferred to a slide
glass, and observed at the same laser intensity with laser-
scanning confocal ﬂuorescence microscopy (Bio-Rad MRC
1024, Bio-Rad Laboratories Inc., CA). The ﬂuorescence
microscopy used a krypton/argon laser for excitation at
488 nm.
RESULTS
The design of aptazymes for HCV replicase and
HCV helicase
General strategy for developing aptazymes using hammerhead
ribozyme was to fuse the binding site of target aptamer into
the stem II region of the ribozyme (Figure 1a). It was based
upon the prediction of stable structure maintaining their
original structures of aptamer and ribozyme with the lowest
conformational energy (DGconf) (7,17). The other strategy was
to select optimized aptazymes showing high ribonuclease
activities upon binding target molecule through serial
in vitro selection by randomizing the residual sequences
except the conserved minimal sequences of ribozyme
(8,17). In our study, the former strategy of rational design
was adopted because of its general applicability to any target
molecules.
Primarily, we attempted to fuse the protein-binding region
of HCV replicase aptamer into the stem II region of the ham-
merhead ribozyme. The structure of HCV replicase aptamer
has two loop–stem structures, and the sequences of the target
protein-binding sites in the two loops are GGCCACAUUGU-
GAGGGGCUC and GGAUCGCAUGGCCGUGUCC (Sup-
plementary Figure 1Sa). If we include the complete
sequences of the aptamer and the ribozyme, the total length
of the fusion conjugate would become 85mer. Since long
sequenceofaptazymeoftensigniﬁcantly decreasesthe activity
of ribozyme (25), and requires a high cost in the synthesis of
the aptazyme, shorter and stabler aptazyme is preferred in
applying it to biosensors. Three kinds of aptazymes were
designed by changing the protein-binding sequences of the
aptamer moiety for the connection of the stem II region of
the hammerhead ribozyme: the 85mer with two binding sites
(type II-A) (Supplementary Figure 1Sa), the 52mer with the
left-hand binding site (type II-B) (Supplementary Figure 1Sb)
and the 52mer with the right-hand binding site (type II-C)
(Supplementary Figure 1Sc). The secondary structure of
each aptazyme was predicted by ‘RNA structure version
4.1’ (26). The dissociation constant (Kd) of each aptazyme
for the HCV replicase was measured using surface plasmon
resonance. The dissociation constants of type II-A, type II-B
and type II-C aptazymes for the HCV replicase were 0.43, 4.43
and 2.90 nM, respectively, suggesting that the aptazyme
comprising the complete binding sites of the replicase yields
10 times higher binding afﬁnity than the one only with the left-
hand side of the binding sites. To ﬁnd out any relationship
between the binding afﬁnity of the aptazyme and its ribozyme
activity, the catalytic activity of each aptazyme was measured
by ﬂuorescence spectrometry in the presence of 100 nM HCV
replicase (Supplementary Figure 2S). Type II-B aptazyme
showed 2 and 3.5 times higher ribozyme activities than
type II-A and type II-C, respectively. Although the type
II-A showed 10 times higher binding afﬁnity to the replicase,
there is no direct correlation between the binding afﬁnity and
the ribozyme activity. Rather, the ribozyme activity of the
aptazyme appears to have a close relationship with conforma-
tional or structural changes around its catalytic site such as the
compactness of ribozyme (25,27), length of stem (19) and
stable secondary structure. Despite the higher binding afﬁnity
of type II-A, the longer sequence of type II-A seems to reduce
its ribozyme activity. Although the afﬁnity of type II-B is
10 times lower than that of type II-A, low nanomolar range
dissociation constant is still effective enough to be used as a
Figure 1. Schemes of various aptazymes designed through conjugation with
thethreestemsofhammerheadribozyme(a)stemIIlinkedaptazymes,(b)stemI
linked aptazymes, (c) stem III linked aptazymes and (d) stem I/III linked
aptazymes.
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aptazyme showing the highest ribozyme activity was selected
for further study on the design of the aptazyme for HCV
replicase.
The aptamer for HCV helicase had the binding site of
beacon shape with one loop and one stem (28). For the con-
jugation of the HCV helicase aptamer with the hammerhead
ribozyme, the helicase-binding site ‘GCAGUAGUGUAUA-
GGC’ in the loop was inserted into the stem II of the ham-
merhead ribozyme, maintaining the original structure of the
aptamer and the ribozyme (Table 1).
Characteristics of conjugated aptazymes for
HCV replicase and HCV helicase
In the case of the conjugated aptazymes through the stem II
region of the hammerhead ribozyme, one interesting observa-
tion was that the blank signals in the absence of any target
proteins were very high owing to the high self-cleavage activ-
ityof the aptazymes (Supplementary Figure 2S). Hammerhead
ribozyme naturally has the self-cleavage activity in metal con-
taining solution (24), and the stem II module of the hammer-
head ribozyme is known to be the most sensitive module in
determining its catalytic activity. To avoid such high blank
signals for the stem II conjugated aptazymes, the stem I or/and
stem III of the hammerhead ribozyme was/were attempted for
the conjugation. We expected that less tight complementary
binding of the ribozyme substrate may induce some reduction
in the self-cleavage activity of the conjugated aptazyme.
With the selected binding regions of the aptamers for HCV
replicase and HCV helicase, conjugated aptazymes were con-
structed by fusing the sequence of the binding regions into the
stem I, II, III and I/III of the hammerhead ribozyme (Figure 1).
Their RNA sequences are shown in Table 1. The substrate
sequence of the stem II conjugated aptazymes was 13mer
RNA, and those of stem I, stem III and stem I/III were
16mer RNAs labeled by 6-Fam at 50 end and dabsyl at
30 end.Allthe aptazymes wereselected topreservethe original
structures of the aptamer-binding site and ribozyme active site
and to have the lowest Gibbs free energy in secondary struc-
ture prediction (Supplementary Figure 3S). The activities of
the stem II, stem I or/and III-conjugated aptazymes for target
proteins were measured using the same sequence substrate.
When the target molecule binds to the aptamer moiety, the
ﬂuorescence intensity from 6-Fam increases over time as the
ribozyme moiety becomes functional. All the aptazymes
showed a somewhat linear relationship between the ribozyme
activity and the concentration of target proteins (Figure 2). To
compare the sensitivity of the detection, i.e. signal to noise
ratio, the ratio of relative reaction rate constants was used (The
activity assay of aptazyme).
Inmostcases ofthemono-aptazymes conjugated with either
stem I, stem II or stem III of the hammerhead ribozyme, the
blank activities for HCV replicase and helicase were nearly
>70% of the activities of the corresponding mono-aptazyme
within the ranges of the detection (50–500 nM) of HCV repli-
case and helicase, respectively. Although the absolute values
of the reaction rate constants of the bis-aptazymes did not
change greatly (i.e.  25–40% increase), their ratios of the
rate constants changed dramatically because the blank rate
constants in the absence of target proteins were greatly
reduced (Figure 2). The blank rate constants of stem II,
stem I mono-aptazymes and stem I/III bis-aptazyme in the
absence of HCV replicase were 0.660, 0.757 and 0.254
min
 1, respectively. The same blank rate constants of the
stem II, stem III mono-aptazymes and stem I/III bis-
aptazyme in the absence of HCV helicase were 0.715,
0.782 and 0.019 min
 1, respectively. The ratios of the rate
constants of the bis-aptazyme for HCV replicase and helicase
were  4 and 50 times higher than that of the corresponding
mono-aptazymes, respectively. This result suggests that
designing bis-aptazymes with high activity to target molecules
and very low blank signals at the same time would become a
useful approach to improve the function of target aptazymes.
In addition, the substrate speciﬁcity of bis-aptazymes for
HCV replicase and HCV helicase were examined. The relative
activity, i.e. the ratio of rate constants, of the bis-aptazymes
were compared in the presence of 200 nM of ovalbumin, BSA,
HCV replicase, HCV helicase and these four protein mixtures.
Figure 2. Theratioofreactionrateconstantsof(a)stemII,stemIandstemI/III
modified aptazymes for HCV replicase and (b) stem II, stem III and stem I/III
modified aptazymesat 10 mM Tris–HCl, 100 mM KCl and 10 mM MgCl2 (pH
7.6). The ratio of reaction rate constants means ‘the ratio of the rate constant in
the presence of protein to that in the absence of protein’. The concentrations of
the aptazymes and substrate in the reaction mixture are 1 mM. Reaction rate
constants were obtained from {ln[(Ft   Fi)/Fi]/Dt}( Ft and Fi are the fluores-
cenceintensitiesat5andat0min,respectively).Theblankrateconstantofstem
II mono-aptazyme, stem I mono-aptazyme and stem I/III bis-aptazymes in the
absence of HCV replicase were 0.660, 0.757 and 0.254 min
 1, respectively.
And the blank rate constants of the stem II mono-aptazyme, stem III mono-
aptazymeandstemI/IIIbis-aptazymesintheabsenceofHCVhelicase(b)were
0.715, 0.782 and 0.019 min
 1, respectively.
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only in the presence of its corresponding target proteins
(Figure 3). The bis-aptazyme activities for HCV replicase
and helicase in BSA and ovalbumin known to have high
nonspeciﬁc binding were nearly similar to the blank activity
in the absence of the target protein. The activities of the bis-
aptazymes in the protein mixture were almost the same as that
for the speciﬁc target protein alone. Figure 3 also shows that at
200 nM of each target protein, the aptazyme for HCV helicase
is more selective than that for HCV replicase by about ﬁve
times. Here, the blank rate constants of bis-aptazymes at
Figure 3a and b were 0.095 and 0.020 min
 1, respectively.
The result clearly shows that the bis-aptazyme is very speciﬁc
and more selective to detect the target molecules.
Why does the bis-aptazyme show low blank signal?
Kinetic mechanism of the hammerhead ribozyme can be
dissected into three steps as follows: (i) the complementation
between ribozyme main strand and substrate, (ii) self-cleavage
of the substrate and (iii) subsequent releasing of the cleaved
substrate (29). In fact, the self-cleavage reaction of the
hammerhead ribozyme starts upon the completion of comple-
mentary binding of the substrate sequence. By introducing an
aptamer in the complementary base-pairing region, i.e. the
stem I or III domain of the ribozyme, the substrate is expected
to show a lower binding afﬁnity to the main strand owing to
reduction in the size of the base-pairing sequence. When sche-
matic diagram of sense–antisense base-pairing is given as
in Figure 4a, the most common stem II conjugated aptazyme
construct would be similar to the schematic diagram in
Figure 4b. Here, the complementary pairing fragments are
divided into two: A and B. To make a construct of lower
binding afﬁnity having shorter complementary sequences in
the ribozyme, conjugating an aptamer in either the stem I or
stem III region is possible (Figure 4c). Then the complemen-
tary pairing fragments are divided into three parts: A, B and C.
Similarly two aptamers can be inserted into both stem I
and stem III regions (Figure 4d). Now, the bis-aptazyme is
divided into four short base-pairing fragments. As the number
of fused aptamers increases, the number of fragments of short
complementary base-pairings increases, resulting in a
decrease in the total number of base pairs involved in the
assembly. Binding afﬁnity based upon the Gibbs free energy
of the complementary base-pairings would decrease in the
order of (b), (c) and (d) in the absence of the target protein
(Table 2). However, since the aptamer can rapidly change the
secondary structure of the aptazyme itself upon binding with
its target protein, the changes in the complementary base-
pairing is hard to predict only with the Gibbs free energy
calculated based on the number of base-pairings under the
static condition before the conformational change.
We wanted to examine whether or not the low blank signal
of the aptazyme in Figure 4d is caused by (i) the decrease in
the number of the complementary base pairings between the
bis-aptazyme and the substrate in the absence of the target
protein, or alternatively, (ii) the subsequent conformational
changes in the aptazyme–substrate complex that occur upon
the binding of the target molecule after the completion of the
complementary base pairings between the bis-aptazyme and
Figure 3. The substrate specificity of the bis-aptazymes for (a) HCV replicase
and (b) HCV helicase. Protein concentrations for the assay were 200 nM of
ovalbumin (Oval), BSA, HCV replicase (Rep) and HCV helicase (Hel). The
mixturesolutionconsistsof200nMofalltheaboveproteinsolutions.Here,the
blankrateconstantsofbis-aptazymesat(a)and(b)were0.095and0.020min
 1,
respectively.
Figure 4. Various types of complementary base-pairing: (a) antisense type,
which has one long complementary base-pairing A fragment; (b) the type of
ribozyme or stem II-conjugated mono-aptazyme, having separated two short
complementary base-pairing fragments of A and B; (c) the type of aptazyme
conjugated with either the stem I or stem III of hammerhead ribozyme, having
threeshorter complementary base-pairingfragmentsofA, B andC; and(d) the
type of bis-aptazyme conjugated in the middle of the stem I and stem III of
hammerhead ribozyme, having the shortest four complementary base-pairing
fragments of A, B, C and D.
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the binding afﬁnity of the substrate upon the binding of the
target molecule is not easy or simple, because the degree of
base-pairing cannot be compared, once the substrate is cleaved
by its ribozyme activity. The hammerhead ribozyme usually
cleaves the non-complementary sequence in the middle of its
stem I and stem III regions except the guanine ribonucleotide
(rG). Using this property, a mutant substrate, whose cleavage
site is replaced with rG, was designed to compare the changes
in the binding afﬁnity to the main strand of the bis-aptazyme
in the presence of the target protein (Figure 5a). The mutant
substrate (100 pmol) with six-carbon linker at 50 end was
immobilized on CNBr modiﬁed agarose beads (7 mmol/
10 ml). Subsequently, the 20 pmol bis-aptazyme labeled with
ﬂuorescein dye was reacted for 5 min with the immobilized
mutant substrate in the presence or absence of the target pro-
teins. Interestingly, the bis-aptazyme did not nearly bind with
the mutant substrate without the target proteins (Figure 5b,
cases II and V). However, in the presence of the target protein,
the bis-aptazyme binds with the mutant substrate very efﬁ-
ciently (Figure 5b, cases III and VI), suggesting that the low
blank signal of the bis-aptazymes is originally produced
owing to the lower degree of base-pairing between the bis-
aptazyme and the substrate. This result also suggests that the
main strand of the bis-aptazyme exposes its complementary
binding sequence to the mutant substrate only when the target
protein binds to the aptamer moiety of the bis-aptazyme, sug-
gesting a true allosteric effect of the aptamer is in function to
control the ribozyme activity.
Design of bis-aptazyme for dual detections
As a next step to construct any possible bis-aptazymes, design
of hetero-bis-aptazyme which can detect two target molecules
simultaneously was attempted. To create the hetero-bis-
aptazyme detecting both HCV replicase and helicase with
only one aptazyme, the target-binding domain of each aptamer
were coupled to the stem I and stem III of the hammerhead
ribozyme following the previous design of the stem I/III con-
jugated bis-aptazyme. Here, each aptamer for HCV replicase
and HCV helicase was inserted into the middle of the stem I
and stem III, respectively (StemI/III(R–H) (Table 1).
The ratio of rate constants of the hetero-bis-aptazyme was
compared at 200 nM of ovalbumin, BSA, HCV replicase,
HCV helicase, and the mixture of HCV replicase and helicase
(Figure 6). The hetero-bis-aptazyme showed a somewhat com-
parable activity with the homo-bis-aptazymes conjugated with
the two identical aptamers in the stem I and stem III in the
presence of HCV replicase or helicase. One interesting
Table 2. The affinity constants of sense/antisense RNA pairs
Ka Antisense Ribozyme or aptazyme (stem II) Monoaptazyme (stem I) Monoaptazyme (stem III) Biaptazyme (stem I/III)
Ka
I 1.635 · 10
29 5.468 · 10
9 2.252 · 10
5 2.475 · 10
12 2.252 · 10
5
Ka
II 2.475 · 10
12 1.4045 1.254 · 10
3 3.81 · 10
2
Ka
III 5.468 · 10
9 15.147 1.2543 · 10
3
Ka
IV 15.147
aKatotal 1.635 · 10
29 1.353 · 10
22 1.729 · 10
15 4.701 · 10
16 1.630 · 10
12
Equilibriumconstants(Ka)werecalculatedfromGibbsfreeenergiesofRNA-RNAinteractions.TheRNA-RNAinteractionswereobtainedfromtheRNAsecondary
structure prediction based on free energy minimization using RNA structure program (4.1 version).
aKatotal ¼ KI
a ·KII
a ·KIII
a ·    ·Kn
a:
Figure 5. (a) The schematic representation of binding test of the bis-aptazyme
and substrate sequence in the presence/absence of target protein. The cleavage
site of substrate, rC, was changed to uncleavage site, rG (red box). The fluor-
escence labeled bis-aptazymes were reacted with an immobilized mutated
substrate(Mu-substrate)for5min.Thefluorescenceofthebeadswereobserved
after washing. (b) Laser confocal microscopic analyses of the interaction be-
tween 20 pmol fluorescence-labeled bis-aptazyme main strand with 100 pmol
substrate were carried out in the presence or in absence of 500 nM target
proteins. I and IV are the bead images after the reactions of the bis-
aptazymes for HCV replicase and helicase, respectively, on the bare agarose
beads without the substrate sequence. II and V are the beads images after the
reactions of the same bis-aptazymes for HCV replicase and helicase, respec-
tively. with the substrate in the absence of the target proteins. III and VI are the
same bead images as II and V except the reaction in the presence of their target
proteins. All the data were obtained after 5 min of hybridization reaction and
subsequent five times washing with the solution mixture of 10 mM Tris–HCl,
100 mM KCland 10mM MgCl2 (pH7.6). The numberson the figure represent
the average fluorescence intensity from the beads.
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aptazyme of the dual functions does not agree with additive
values of the two homo-bis-aptazymes in the presence of the
mixture of HCV replicase and HCV helicase, but its value is
rather in the middle of the two homo-bis-aptazymes (refer to
Figures 3 and 6), suggesting that its selectivity to the target
proteins are somewhat averaged out with yet unknown
reasons. The nonspeciﬁc activities of the bis-aptazyme for
ovalbumin and BSA were very low and its blank signal was
quite low like that of the above homo-bis-aptazymes. The
results indicate that a single molecule, i.e. bis-aptazyme alone,
can be easily and efﬁciently developed as sensors for multiple
targets.
Especially, HCV replicase and HCV helicase are NS5b and
NS3 proteins of HCV virus, expressed during its infection into
the host cells. As the concentrations of the antigen proteins
might be very low during the early stage of the infection, it
would be difﬁcult and challenging to detect them with normal
ELISA assay. If there are any means to amplify the detected
signals for the target proteins, improved diagnosis would be
possible with minute quantity of patient sample. The hetero-
bis-aptazyme of dual functions shown in this study is quite
suitable for this purpose, and can be used to detect both target
proteins allowing the presence of HCV, and signal ampliﬁca-
tion is possible with longer analysis time by simply adding
more ribozyme substrate.
DISCUSSION
In this study, fusion aptazyme combining aptamer and
ribozyme was developed as an in situ sensor for the detection
of HCV virus related proteins. The aptazyme shows target-
speciﬁc catalytic ribozyme activity upon binding to the target
molecules such as HCV replicase and helicase. To apply the
aptazyme to in situ sensor, a key concern is that some
aptazymes show high blank self-cleavage activities even in
the absence of target molecules, resulting in somewhat narrow
linear range of detecting target molecules.
To reduce the blank self-cleavage activity, we fused
aptamer moieties into the stem I and stem III regions of the
hammerhead ribozyme to have a stable structure of the ham-
merhead ribozyme with lower degree of complementary base-
pairing between the aptazyme main strand and the substrate
strand. The bis-aptazyme did show a very low blank signal and
hence high sensitivity, i.e. signal to noise ratio, to the target
molecule. However, the mono-aptazyme having one aptamer
unit either in the stem I, stem II or stem III region of the
ribozyme did not show such properties. The special features
of the bis-aptazyme appear to originate from allosteric con-
formational changes of the aptazyme upon binding to the
target protein. There are two possibilities in its conformational
changes. The one possibility is that although the complemen-
tary base-pairings between the bis-aptazyme and the substrate
occur rapidly, the self-cleaving ribozyme activity is not shown
yet in the absence of the target molecule owing to possibly
long and ﬂexible structure of the bis-aptazyme. But upon its
binding with the target molecules, the bis-aptazyme changes
into a rigid structure and induces its high ribozyme activity.
The other possibility is that the conformational changes in the
bis-aptazyme induced by its binding to the target molecule is
quite fast, so that it increases the binding rate between the bis-
aptazyme strand and the substrate, which subsequently
enhances the ribozyme activity. The result of this report sug-
gests that the latter possibility is more probable. It appears that
the conformational change of the aptazymes triggered by the
binding of the target molecule induces a faster binding of the
main strand of the bis-aptazyme to the substrate strand.
To conﬁrm the ﬁndings in our report, the stem II/III
modiﬁed bis-aptazyme was also compared with the stem
I/III modiﬁed bis-aptazyme. If the low blank signal from
the stem I/III modiﬁed bis-aptazyme was caused only by
the two aptamer-binding sites, i.e. binding of target molecule,
the stem II/III modiﬁed bis-aptazyme should also exhibit the
similar low blank signal. However, the stem II/III modiﬁed
bis-aptazyme showed much higher blank signal, similar to that
of the stem I, stem II or stem III modiﬁed mono-aptazymes
(Supplementary Figure 4S). This result again supports that the
positions of coupling the aptamer moiety and the number of
the aptamers are important in the designing bis-aptazyme
without blank signal.
Moreover, the newly designed bis-aptazyme in this study
displayed slightly higher ribozyme activity than the corre-
sponding other mono-aptazymes by 10–20%. One of the rea-
sons of showing its higher catalytic activity would be that the
bis-aptazyme having two binding sites for the target protein
might have higher collision frequency compared with the
mono-aptazyme under the same condition. The additional
increase in the activity would be caused by faster releasing
kinetics of the cleaved substrate owing to a reduction in the
size ofthe complementary base-pairing sequences betweenthe
aptazyme main strand and the substrate.
This study on developing the bis-aptazyme with very low
blank signal, but with high sensitivity and speciﬁcity for target
protein would be meaningful in several points as follows:
(i) in situ detection or analysis of target molecule is possible
by designing a fusion aptazyme; (ii) secondary molecules such
as secondary Ab and conjugated enzyme are not needed unlike
Figure 6. Thehetero-bis-aptazymehavingtwoaptamerregionsforHCVrepli-
case and helicase into stem I and stem III of one hammerhead ribozyme,
respectively, was designed, and its activities were compared for 200 nM oval-
bumin(Oval),BSA,HCVreplicase(Rep),HCVhelicase(Hel),andthemixture
of 200 nM HCV replicase and 200 nM HCV helicase (Rep/Hel). The blank
rate constant of the hetero-bis-aptazyme in the absence of the two proteins was
0.091 min
 1.
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applied to any aptamers; (iv) more sensitive and versatile
sensors can be designed; and (v) multiple sensors can be
designed and so on. Further, versatile bis-aptazymes can be
developed for protein and small molecule sensors in bio-
MEMS, tools for proteomics (30), in vivo/in vitro medical
diagnosis and prognosis, and tools for gene knock-out, gene
regulation (31,32) and gene therapy (33).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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